Therapeutic Inertia with Initial Low-Dose Quadruple Combination Therapy for Hypertension: Results from the QUARTET Trial

Nelson Wang, Amy Von Huben, Simone Marschner, Mark R. Nelson, Janis M. Nolde, Markus P. Schlaich, Gemma Figtree, Graham S. Hillis, Tim Usherwood, Christopher M. Reid, John Chalmers, Shirley Jansen, Emily R. Atkins, Laurent Billot, Clara Chow, Anthony Rodgers

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)

Abstract

BACKGROUND: Low-dose combinations are a promising intervention for improving blood pressure (BP) control but their effects on therapeutic inertia are uncertain. METHODS: Analysis of 591 patients randomized to an ultra-low-dose quadruple pill or initial monotherapy. The episode of therapeutic inertia was defined as a patient visit with a BP of >140/90 mm Hg without intensification of antihypertensive treatment. We compared the frequency of therapeutic inertia episodes between Quadpill and initial monotherapy as a proportion of the total population (intention-to-treat analysis with the denominator being all participants randomized) and as a proportion of people with uncontrolled BP (with the denominator being participants with uncontrolled BP). RESULTS: Therapeutic inertia occurred in fewer participants randomized to Quadpill compared with monotherapy. For example, among the 390 participants with a 6-month follow-up, therapeutic inertia according to unattended BP was 21/192 (11%) versus 45/192 (23%), P=0.002. There were similar rates of therapeutic inertia among those with uncontrolled unattended BP in each group (all P>0.4). Consistent observations were seen with the use of attended office BP measures. The major determinants of not intensifying treatment during follow-up were BP readings that were close to target and large improvements in BP compared with the previous visit. CONCLUSIONS: Among all treated individuals, low-dose Quadpill reduced the number of therapeutic inertia episodes compared with initial monotherapy. After the first follow-up visit, most high BP values did not lead to treatment intensification in both groups. Education is needed about the importance of treatment intensification despite a significant improvement in BP or BP being close to target. REGISTRATION: URL: https://anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12616001144404; Unique identifier: ACTRN12616001144404.

Original languageEnglish
Pages (from-to)1087-1094
Number of pages8
JournalHypertension
Volume81
Issue number5
DOIs
Publication statusPublished - May 2024

Fingerprint

Dive into the research topics of 'Therapeutic Inertia with Initial Low-Dose Quadruple Combination Therapy for Hypertension: Results from the QUARTET Trial'. Together they form a unique fingerprint.

Cite this